BMGL — Basel Medical Balance Sheet
0.000.00%
Last trade - 00:00- $17.34m
- $12.40m
- SG$11.32m
Annual balance sheet for Basel Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 1.66 | 1.31 | 2.04 | 9.8 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 13.9 | 13.3 | 12.4 | 2.49 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 15.7 | 14.8 | 16.2 | 13.1 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 1.18 | 0.579 | 0.058 | 3.45 |
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 16.8 | 15.4 | 16.3 | 16.9 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 7.19 | 6.47 | 7.16 | 10.7 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Liabilities | 13.1 | 9.89 | 8.75 | 12 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 3.71 | 5.49 | 7.56 | 4.86 |
| Total Liabilities & Shareholders' Equity | 16.8 | 15.4 | 16.3 | 16.9 |
| Total Common Shares Outstanding |